dpuleo19

$AMLX, following the Bio Techs

做多
dpuleo19 已更新   
NASDAQ:AMLX   Amylyx Pharmaceuticals, Inc.
The health care industry is being leading the charge, AMLX is the proof of that. This recent IPO just broke out of a good looking cup & handle pattern. Also, IBD is giving a 99 relative strength rating.

So, I enter today with a small position. A "pilot position", as Mark Minervini would say. The market is still under pressure so I'm testing it.

As this stock is a highly volatile I'll play for a 3:1 risk/reward.

评论:
Just put my stop loss at breakeven
评论:
I sold my position at breakeven just be sure. The thing is that the price hasn't break support at its MAs.

I'll keep a close eye on this one for thise week's action.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。